logo

Zevra Therapeutics Inc (ZVRA) Stock: A Year of Highs and Lows in the Market

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Zevra Therapeutics Inc’s current trading price is -17.52% away from its 52-week high, while its distance from the 52-week low is 91.67%. The stock’s price range for this period has been between $4.20 and $9.76 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.7 million for the day, a number notably higher than the average daily volume of 0.42 million over the last three months.

Zevra Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $9.76 on 11/25/24, while the lowest price for the same period was registered at $4.20 on 07/05/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Zevra Therapeutics Inc (ZVRA) has experienced a quarterly decline of -16.84% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 429.67M and boasts a workforce of 69 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.34, with a change in price of -0.42. Similarly, Zevra Therapeutics Inc recorded 500,504 in trading volume during the last 100 days, posting a change of -4.96%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ZVRA stands at 0.86. Similarly, the long-term debt-to-equity ratio is also 0.85.

ZVRA Stock Stochastic Average

Zevra Therapeutics Inc’s raw stochastic average for the past 50 days is presently 48.28%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 80.00%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 46.54% and 32.07%, respectively.

ZVRA Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -3.48% this year. Over the last six months, there has been a weaker performance of 10.27%. The price of ZVRA leaped by -0.98% during the last 30 days period. For the last 5-days stocks have improved 3.34%.

Most Popular